from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2165c/-

LFCtreatmentdescriptionclass of inhibitor

0.242

Amikacinug/mL Amikacintranslation

-0.185

Cap5-10ug/mL Capreomycintranslation

0.348

Rox10-50 ug/mL Roxithromycintranslation

-0.481

SM2-5 ug/mL Streptomycintranslation

0.744

Tet5-10 ug/mL Tetracyclinetranslation

-0.630

Rif0.2-5ug/mL Rifampicintranscription

-0.335

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.213

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.888

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.462

CPZ10-50 ug/mL Chlorpromazinerespiration

0.783

Clofazimine10-13 ug/mL Clofaziminerespiration

0.292

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.124

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.867

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.345

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.368

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.137

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.337

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.201

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.734

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.029

KCN5-20 ug/mL Potassium cyaniderespiration

0.114

NaN30.2-2 mM Sodium aziderespiration

-1.441

Nigericin50 uM Nigericinrespiration

0.078

TRC10-150 ug/mL Triclosanrespiration

0.450

TRZ10-25 ug/mL Thioridazinerespiration

1.394

Valinomycin0.5-10 uM Valinomycinrespiration

1.749

ZnSO42 mM ZnSO4respiration

-0.988

menadione6-10 ug/mL Menadionerespiration

0.141

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.309

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.123

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.403

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.016

NRP_1Non-replicating persistence stage 1dosRassociated

0.631

Amp0.2mg/mL AmpicillincellWall

1.249

Cephalexin20-100 ug/mL CephalexincellWall

-0.633

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.397

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.537

EMB10-20 ug/mL EthambutolcellWall

1.111

Eta12-40 ug/mL EthionamidecellWall

0.980

INH0.2-0.4 ug/mL IsoniazidcellWall

0.285

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.333

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.005

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.239

BZA0.12 mg/mL BenzamidearomaticAmides

-0.160

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.240

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.000

H2O24 mM hydrogen peroxideDNAdamaging

-0.902

Levo10 ug/mL LevofloxacinDNAdamaging

-1.068

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.615

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.386

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.714

UVUV-irradiationDNAdamaging

-0.439

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.251

Antimycin12.5-50 ug/mL Antimycin A?

-0.314

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.255

PA_110-50 ug/mL Antitubercular compound PA-1?

0.432

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.771

PA8240.2-2 ug/mL PA-824?

0.861

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.070

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.283

Verapamil50 uM Verapamil?

-0.984

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.539

methoxatin10-20 ug/mL Methoxatin?